{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:25:15Z","timestamp":1791325515685,"version":"4.3.1"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T00:00:00Z","timestamp":1704931200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"International Treatment Preparedness Coalition\u2019s"},{"name":"Make Medicines Affordable Campaign","award":["ITPC\/MV\/2021"],"award-info":[{"award-number":["ITPC\/MV\/2021"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Worldwide, more than 39 million individuals are living with human immunodeficiency virus (HIV), 296 million with chronic hepatitis B (HBV), and 58 million with chronic hepatitis C (HCV). Despite successful treatments for these blood-borne viruses (BBVs), &amp;gt;1.7 million people die per annum. To combat this, the World Health Organization recommended implementing triple testing for HIV, HBV, and HCV. This systematic review aims to provide evidence for this policy, by identifying the prevalence of these BBVs and discussing the costs of available triple tests.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Medline, Embase, and Global Health were searched to identify articles published between 1 January and 24 February 2023. Included studies reported the prevalence of HIV (anti-HIV 1\/2 antibodies), HBV (hepatitis B surface antigen) and HCV (anti-HCV antibodies). Results were stratified into risk groups: blood donors, general population, healthcare attendees, individuals experiencing homelessness, men who have sex with men, people who use drugs, pregnant people, prisoners, and refugees and immigrants.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>One hundred seventy-five studies sampling &amp;gt;14 million individuals were included. The mean prevalence of HIV, HBV, and HCV was 0.22% (standard deviation [SD], 7.71%), 1.09% (SD, 5.80%) and 0.65% (SD, 14.64%) respectively. The mean number of individuals testing positive for at least 1 BBV was 1.90% (SD, 16.82%). Therefore, under triple testing, for every individual diagnosed with HIV, another 5 would be diagnosed with HBV and 3 with HCV. Testing for all 3 viruses is available for US$2.48, marginally more expensive than the lowest-priced isolated HIV test ($1.00).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>This article highlights a potential avenue for healthcare improvement by implementing combination testing programs. Hopefully, this will help to achieve the Sustainable Development Goal of elimination of these BBV epidemics by 2030.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ofid\/ofad666","type":"journal-article","created":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T14:58:14Z","timestamp":1704985094000},"source":"Crossref","is-referenced-by-count":20,"title":["Combined \u201cTest and Treat\u201d Campaigns for Human Immunodeficiency Virus, Hepatitis B, and Hepatitis C: A Systematic Review to Provide Evidence to Support World Health Organization Treatment Guidelines"],"prefix":"10.1093","volume":"11","author":[{"given":"Natasha","family":"Beard","sequence":"first","affiliation":[{"name":"School of Medicine, School of Public Health, Imperial College London , London , United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6494-7645","authenticated-orcid":false,"given":"Andrew","family":"Hill","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Therapeutics, University of Liverpool , Liverpool , United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,1,11]]},"reference":[{"key":"2024021314504788500_ofad666-B1","author":"Joint United Nations Programme on HIV\/AIDS"},{"key":"2024021314504788500_ofad666-B2","author":"World Health Organization"},{"key":"2024021314504788500_ofad666-B3","author":"Clinton Health Access Initiative"},{"key":"2024021314504788500_ofad666-B4","author":"World Health Organization"},{"key":"2024021314504788500_ofad666-B5","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S2468-1253(22)00050-4","article-title":"Worldwide prevalence of hepatitis B virus and hepatitis C virus among patients with cirrhosis at country, region, and global levels: a systematic review","volume":"7","author":"Alberts","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2024021314504788500_ofad666-B6","author":"Hepatitis B Foundation"},{"key":"2024021314504788500_ofad666-B7","author":"United Nations Children\u2019s Fund"},{"key":"2024021314504788500_ofad666-B8","author":"Clinton Health Access Initiative"},{"key":"2024021314504788500_ofad666-B9","author":"World Health Organization"},{"key":"2024021314504788500_ofad666-B10","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1053\/j.gastro.2018.10.024","article-title":"Status of direct-acting antiviral therapy for HCV infection and remaining challenges","volume":"156","author":"Baumert","year":"2019","journal-title":"Gastroenterology"},{"key":"2024021314504788500_ofad666-B11","author":"World Health Organization"},{"key":"2024021314504788500_ofad666-B12","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1002\/hep.27337","article-title":"Clinical outcomes of hepatitis B virus coinfection in a United States cohort of hepatitis C virus\u2013infected patients","volume":"60","author":"Kruse","year":"2014","journal-title":"Hepatology"},{"key":"2024021314504788500_ofad666-B13","doi-asserted-by":"crossref","first-page":"713981","DOI":"10.3389\/fmed.2021.713981","article-title":"HBV\/HIV coinfection: impact on the development and clinical treatment of liver diseases","volume":"8","author":"Cheng","year":"2021","journal-title":"Front Med"},{"key":"2024021314504788500_ofad666-B14","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3748\/wjg.v8.i4.577","article-title":"Hepatitis C and HIV coinfection\u2014a review","volume":"8","author":"Maier","year":"2002","journal-title":"World J Gastroenterol"},{"key":"2024021314504788500_ofad666-B15","author":"World Health Organization"},{"key":"2024021314504788500_ofad666-B16","author":"World Health Organization (WHO)"},{"key":"2024021314504788500_ofad666-B17","author":"European Centre for Disease Prevention and Control"},{"key":"2024021314504788500_ofad666-B18","author":"World Health Organization (WHO)"},{"key":"2024021314504788500_ofad666-B19","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2024021314504788500_ofad666-B20","author":"National Institute for Health and Care Excellence"},{"key":"2024021314504788500_ofad666-B21","author":"Centers for Disease Control and Prevention"},{"key":"2024021314504788500_ofad666-B22","author":"World Health Organization"},{"key":"2024021314504788500_ofad666-B23","author":"United Nations Refugee Agency"},{"key":"2024021314504788500_ofad666-B24","author":"World Health Organization"},{"key":"2024021314504788500_ofad666-B25","author":"Institute of Health Economics"},{"key":"2024021314504788500_ofad666-B26","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jclinepi.2011.11.014","article-title":"Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement","volume":"65","author":"Hoy","year":"2012","journal-title":"J Clin Epidemiol"},{"key":"2024021314504788500_ofad666-B27","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/hiv.12364","article-title":"Incorporating HIV\/hepatitis B virus\/hepatitis C virus combined testing into routine blood tests in nine UK emergency departments: the \u201cgoing viral\u201d campaign","volume":"17","author":"Orkin","year":"2016","journal-title":"HIV Med"},{"key":"2024021314504788500_ofad666-B28","author":"Clinton Health Access Initiative"},{"key":"2024021314504788500_ofad666-B29","author":"World Hepatitis Alliance"},{"key":"2024021314504788500_ofad666-B30","doi-asserted-by":"crossref","first-page":"e0235036","DOI":"10.1371\/journal.pone.0235036","article-title":"Sensitivity and specificity of commercially available rapid diagnostic tests for viral hepatitis B and C screening in serum samples","volume":"15","author":"Jargalsaikhan","year":"2020","journal-title":"PLoS One"},{"key":"2024021314504788500_ofad666-B31","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12985-018-1060-1","article-title":"Systematic review and meta-analysis of HIV, HBV and HCV infection prevalence in Sudan","volume":"15","author":"Badawi","year":"2018","journal-title":"Virol J"},{"key":"2024021314504788500_ofad666-B32","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2105\/AJPH.91.1.31","article-title":"Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness","volume":"91","author":"Rosenberg","year":"2001","journal-title":"Am J Public Health"},{"key":"2024021314504788500_ofad666-B33","author":"Business Insider Africa"},{"key":"2024021314504788500_ofad666-B34","author":"Clinton Health Access Initiative"},{"key":"2024021314504788500_ofad666-B35","first-page":"962","article-title":"Guidelines for the prevention and treatment of hepatitis C (2019 version)","volume":"27","author":"Chinese Society of Hepatology","year":"2019","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"2024021314504788500_ofad666-B36","author":"Canadian Agency for Drugs and Technologies in Health"},{"key":"2024021314504788500_ofad666-B37","author":"Gilead Sciences"},{"key":"2024021314504788500_ofad666-B38","doi-asserted-by":"crossref","first-page":"ofy069","DOI":"10.1093\/ofid\/ofy069","article-title":"Usefulness of simultaneous screening for HIV- and hepatitis C\u2013specific antibodies and hepatitis B surface antigen by capillary-based multiplex immunochromatographic rapid test to strengthen prevention strategies and linkage to care in childbearing-aged women living in resource-limited settings","volume":"5","author":"Mboumba Bouassa","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"2024021314504788500_ofad666-B39","author":"Hill"},{"key":"2024021314504788500_ofad666-B40","doi-asserted-by":"crossref","first-page":"e0149568","DOI":"10.1371\/journal.pone.0149568","article-title":"Rapid syphilis testing is cost-effective even in low-prevalence settings: the CISNE-PERU experience","volume":"11","author":"Mallma","year":"2016","journal-title":"PLoS One"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofad666\/55433709\/ofad666.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/11\/2\/ofad666\/56670000\/ofad666.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/11\/2\/ofad666\/56670000\/ofad666.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T14:51:12Z","timestamp":1707835872000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofad666\/7516102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,11]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofad666","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,2]]},"published":{"date-parts":[[2024,1,11]]},"article-number":"ofad666"}}